As TRIM56 has been revealed to promote radiotherapy tolerance in gliomas, our finding that SP1 drives TRIM56 transcription provides evidence for the mechanism through which SP1 promotes glioma radiotherapy resistance. This evidence concerns the gene TRIM56 and central nervous system cancer.